- Pemetrexed-Erlotinib, Pemetrexed Alone, or Erlotinib Alone as Second-Line Treatment for East Asian and Non-East Asian Never-Smokers with Locally Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer: Exploratory Subgroup Analysis of a Phase II Trial
-
Lee DH, Lee JS, Wang J, Hsia TC, Wang X, Kim J, Orlando M
- KMID: 2403379
- Cancer Res Treat.
- 2015 Oct;47(4):616-629.
- doi: 10.4143/crt.2014.051
PURPOSE: This subgroup analysis of a phase II trial was conducted to assess possible ethnicity-based trends in efficacy and safety in East Asian (EA) and non-EA populations with nonsquamous non-small... -
- CITED
-
- Close
- SHARE
-
- Close
